Immuron Limited - Warrants (12/05/2022) Common Stock

As of the most recent data (December 2025), IMRNW shows a common stock of $96M. That compares with $89M in the prior-year period — up 8.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMRNW's common stock is now $96M (was $89M) — a 8.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immuron Limited - Warrants (12/05/2022) is outperforming or lagging.

Tracking IMRNW's common stock over time shows whether Immuron Limited - Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $96M That compares with $89M in the prior-year period — up 8.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Immuron Limited - Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $96M) with ownership activity and broader fundamentals.

Immuron Limited - Warrants (12/05/2022)'s common stock is $96M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.